Related Experiment Video
Updated: Apr 26, 2026

Author Spotlight: Investigating HR-Dependent Cardiac Function in Mouse Models Through a Novel Atrial-Pacing Approach
Published on: July 21, 2023
Heart diastolic dysfunction in patients with systemic sclerosis
Michał Ciurzyński1, Piotr Bienias1, Katarzyna Irzyk1
1Department of Internal Medicine and Cardiology, Medical University of Warsaw, Warsaw, Poland.
Insights
Systemic sclerosis (SSc) patients show impaired left and right ventricular diastolic function, which worsens over time for the left ventricle. Elevated tissue inhibitors of metalloproteinase-1 (TIMP-1) levels correlate with diastolic dysfunction in SSc.
Area of Science:
- Cardiology
- Rheumatology
- Biomarkers
Background:
- Limited data exist on ventricular diastolic function in systemic sclerosis (SSc).
- The relationship between diastolic dysfunction and matrix remodeling biomarkers in SSc is not well-defined.
Purpose of the Study:
- To assess left ventricular (LV) and right ventricular (RV) diastolic function in SSc patients.
- To evaluate changes in diastolic function over time (≥1 year follow-up).
- To investigate the association between diastolic function and serum tissue inhibitors of metalloproteinase-1 (TIMP-1) levels.
Main Methods:
- Prospective study of 111 SSc patients and 21 controls.
- Transthoracic echocardiography for LV and RV diastolic function assessment.
- Serum TIMP-1 levels measured at baseline and follow-up (mean 3.0 ±1.1 years).
Main Results:
- Impaired LV relaxation in 34% of SSc patients vs. 5% of controls (p < 0.001).
- Lower mean E/A ratio in SSc patients, decreasing significantly after follow-up (p = 0.02).
- Elevated serum TIMP-1 levels at follow-up correlated with echocardiographic parameters (E/E').
Conclusions:
- LV and RV diastolic relaxation are impaired in SSc patients.
- LV diastolic function deteriorates over time in SSc.
- TIMP-1 serum levels are linked to LV diastolic function and matrix remodeling in SSc.
Introduction:
There are limited data on left (LV) and right ventricular (RV) diastolic function in systemic sclerosis (SSc) patients especially in relation to biomarkers of matrix remodeling. The aim of the study was to analyze LV and RV myocardial diastolic function in SSc patients at baseline and after at least 1 year of follow-up and its relation to serum tissue inhibitors of metalloproteinase 1 (TIMP-1) level.
Material And Methods:
We prospectively studied 111 SSc patients (101 female, 10 male, age 54.2 ±13.8 years) and 21 age-matched controls (18 female, 3 male, age 49.3 ±10.5 years). After at least 1 year of observation (3.0 ±1.1 years) we reevaluated 69 of the SSc patients. Transthoracic echocardiography (Philips, iE33) for assessment of LV and RV diastolic function was performed and TIMP-1 serum level was measured.
Results:
Impaired LV relaxation was observed in 38 (34%) SSc patients and in 1 (5%) of the controls (p < 0.001). The mean E/A ratio was lower in patients with SSc than in controls (p = 0.002) and significantly decreased after the follow-up period (p = 0.02). Impaired RV relaxation was detected in 25 (22.5%) SSc patients and in 1 (5%) control subject (p < 0.001) but did not deteriorate after follow-up. Mean serum level of TIMP-1 was significantly elevated in the follow-up group compared to baseline examination (p = 0.0001). Serum TIMP-1 level correlated positively with E/E', both septal and lateral (r = 0.4, p = 0.002 and r = 0.32, p = 0.01).
Conclusions:
The LV and RV relaxation is impaired in SSc patients. Moreover, left ventricular diastolic function deteriorated after the follow-up period. The TIMP-1 serum levels correlate with echocardiographic parameters, providing a potent link for LV diastolic function and matrix remodeling in patients with SSc.
Related Concept Videos
Cardiomyopathy IV: Restrictive Cardiomyopathy
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Pathophysiology of Heart Failure
Rheumatic Heart Disease I: Introduction
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

